Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07493005
Eligibility Criteria:
Inclusion Criteria:
Diagnosis of definite vestibular migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria
Age between 18 and 60 years
Confirmation of vestibular migraine diagnosis using the vestibular migraine diagnostic scale
Not receiving acute pharmacological treatment for vestibular migraine at the time of enrollment
Ability to perform daily activities independently
No visual impairment or eye disease that would interfere with the evaluation or rehabilitation process
Ability to understand and comply with study procedures
Provision of written informed consent
Exclusion Criteria:
Presence of medical contraindications to the head movements required during vestibular rehabilitation (e.g., severe cervical disorders)
Intolerance to virtual reality equipment or the presence of visual or balance problems preventing virtual reality use
Presence of severe comorbid conditions, such as life-threatening disease, severe cognitive impairment, neurological disorder, or severe psychiatric disorder
Presence of a central nervous system disorder
Diagnosis of any vestibular disorder other than vestibular migraine
Inability or unwillingness to regularly perform home-based vestibular rehabilitation exercises or virtual reality-based rehabilitation sessions
Failure to complete the objective and subjective assessment tests
Physical disability preventing walking
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT07493005
Study Brief:
Protocol Section:
NCT07493005